Niraparib is used as first-line maintenance treatment in patients with advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. It is also used as maintenance treatment in patients with recurrent ovarian cancer, fallopian tube cancer, or primary peritoneal cancer.